Designing a VAR2CSA-based vaccine to prevent placental malaria.
about
Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity.The structural basis for CD36 binding by the malaria parasite.Vaccines against malaria-still a long way to go.Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report.Pre-clinical and clinical development of the first placental malaria vaccine.Severe malaria: what's new on the pathogenesis front?In vitro inhibition and reversal of Plasmodium falciparum cytoadherence to endothelium by monoclonal antibodies to ICAM-1 and CD36.VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.PFI1785w: A highly conserved protein associated with pregnancy associated malaria.Plasmodium falciparum PfEMP1 Modulates Monocyte/Macrophage Transcription Factor Activation and Cytokine and Chemokine Responses.Quantitative Proteomic Profiling Reveals Novel Plasmodium falciparum Surface Antigens and Possible Vaccine Candidates.Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.Enzymatic Synthesis of Homogeneous Chondroitin Sulfate Oligosaccharides.An upstream open reading frame (uORF) signals for cellular localization of the virulence factor implicated in pregnancy associated malaria.Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes.Recent advances in the molecular epidemiology of clinical malaria
P2860
Q30245481-29B708B6-C9BC-411D-98B3-ADC83A01DBCCQ34541105-A17D5AE7-EC18-483E-8479-2B0465EA7D96Q34556687-5BE17680-DDD1-4FAF-8270-B17D1AE640BDQ37263318-7AD295B0-F370-4D58-8F61-B7CA36A46313Q38691920-EFE63FE8-A369-4786-BDCD-D5C22252F1E0Q38964820-C64E697F-33DB-42DF-A4C6-DA072495A4A0Q39284275-1FE24195-9B63-4E19-88E2-FC2C50F9E850Q40670564-1D5AF066-4CFA-4F0E-B9DF-BD7242020DB0Q46338646-4DF48E1B-C288-42A1-8102-DD39871107C3Q47095242-A98E96D8-200B-4B17-B311-328AAB15376DQ47377549-D8D160B1-6ED2-464C-B7DD-2989879104A7Q48023771-6441E4C6-4E27-4AE7-ACD1-DCEC773A52A8Q48366844-B94E7C76-2658-44CA-96F0-CAB498E86814Q52648637-92103147-2067-45AF-B417-0D3ABE09D2F4Q54258919-6470F75B-87B7-4B3D-8AFF-27C14226BDF6Q56355140-04575B30-FE82-49D0-8E3E-F5DFA20E9FEC
P2860
Designing a VAR2CSA-based vaccine to prevent placental malaria.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@ast
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@en
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@nl
type
label
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@ast
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@en
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@nl
prefLabel
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@ast
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@en
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@nl
P2860
P921
P1433
P1476
Designing a VAR2CSA-based vaccine to prevent placental malaria.
@en
P2093
Michal Fried
P2860
P304
P356
10.1016/J.VACCINE.2015.10.011
P407
P5008
P577
2015-10-12T00:00:00Z
2015-12-22T00:00:00Z